We are live on ! Find out more
NDRAW

ENDRA Life Sciences Inc. Warrants
NDRAW

Delisted

NDRAW was delisted on the 12th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $9K invested in ENDRA Life Sciences Inc. Warrants in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$16.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$9K +$16.4K +16,450 +2,350%

NDRAW Hedge Fund Activity: Q4 2018 in Review

1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q4 2018, worth a combined $9K.

Fund positioning in NDRAW was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $16.4K.

  • 1 institutional investor held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $9K of ENDRA Life Sciences Inc. Warrants stock for Q4 2018.
  • 0 funds opened new ENDRA Life Sciences Inc. Warrants positions in Q4 2018 and 0 closed out.
  • The largest ENDRA Life Sciences Inc. Warrants buyer in Q4 2018 was UBS Group, an estimated $16.4K added.

Based on aggregated 13F filings for Q4 2018.